Reuters logo
BRIEF-Takeda gets European conditional marketing authorization for Adcetris
October 31, 2012 / 9:06 AM / 5 years ago

BRIEF-Takeda gets European conditional marketing authorization for Adcetris

LONDON, Oct 31 (Reuters) - Takeda Pharmaceutical Co Ltd : * Millennium and Takeda announce European conditional marketing authorization

for adcetris (brentuximab vedotin) * Millenium - Takeda intends to launch adcetris across Europe, with the first

launches planned in the coming weeks

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below